Nanospectra Biosciences nanospectra.com


Public lists: Medical Devices (6146)

Nanospectra Biosciences is commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. AuroLase Therapy utilizes the "optical tunability" of a new class of nanoparticles that can convert light into heat to thermally destroy a solid tumor. These particles (AuroShell particles, also referred to as nanoshells in scientific literature) are designed to absorb near-infr...Show all

Nanospectra Biosciences is commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. AuroLase Therapy utilizes the...Show all

Company (Alive / Active)

Phone: 713-842-2720

Fax:

8285 EL Rio Street
Suite 150
Houston, 77054
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Nanospectra Biosciences $9.9M Feb 10, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Nanospectra Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy Jan 16, 2013 Dec 15, 2015 Patent
Devices and methods for extracorporeal ablation of circulating cells Feb 29, 2008 Nov 15, 2011 Patent